---
title: "Tellgen's shareholder Rongzhen Investment plans to reduce its holdings by no more than 0.71%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/242763490.md"
description: "According to the Zhitong Finance APP, Tellgen announced that its shareholder Shanghai Rongzhen Investment Group Co., Ltd. (\"Rongzhen Investment\") will reduce its holdings of the company's shares by no more than 1.15 million shares (accounting for 0.71% of the company's total share capital) through centralized bidding on the stock exchange or block trading within three months after the disclosure of this announcement, starting from three trading days after the announcement"
datetime: "2025-06-02T08:55:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/242763490.md)
  - [en](https://longbridge.com/en/news/242763490.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/242763490.md)
generator: "portal-rs"
---

# Tellgen's shareholder Rongzhen Investment plans to reduce its holdings by no more than 0.71%

According to the announcement from Zhitong Finance APP, Tellgen (300642.SZ) announced that its shareholder Shanghai Rongzhen Investment Group Co., Ltd. ("Rongzhen Investment") will reduce its holdings of the company's shares by no more than 1.15 million shares (accounting for 0.71% of the company's total share capital) through centralized bidding on the stock exchange or block trading within three months after the disclosure of this announcement, starting from three trading days after the announcement

### Related Stocks

- [300642.CN](https://longbridge.com/en/quote/300642.CN.md)

## Related News & Research

- [13:49 ETVascarta Outlines Proposed Mechanistic Link Between VAS-101's (Vasceptor®) Vascular and Red Blood Cell Effects in Sickle Cell Disease](https://longbridge.com/en/news/296524035.md)
- [17:15 ETHost Defense® Launches New Functional Mushroom Supplement for Pets](https://longbridge.com/en/news/296402242.md)
- [Curql invests in pet healthcare platform Wagmo](https://longbridge.com/en/news/296396050.md)
- [04:20 ETSphingoTec to Engage with Clinical and Industry Partners at Major 2026 Conferences](https://longbridge.com/en/news/296322953.md)
- [Dicot Pharma says three LIB-01 erectile dysfunction trial abstracts win oral slots at SMSNA meeting](https://longbridge.com/en/news/296312317.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**